These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36221151)

  • 1. The efficacy of azithromycin to prevent exacerbation of non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled studies.
    Li K; Liu L; Ou Y
    J Cardiothorac Surg; 2022 Oct; 17(1):266. PubMed ID: 36221151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.
    Wong C; Jayaram L; Karalus N; Eaton T; Tong C; Hockey H; Milne D; Fergusson W; Tuffery C; Sexton P; Storey L; Ashton T
    Lancet; 2012 Aug; 380(9842):660-7. PubMed ID: 22901887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide antibiotics for bronchiectasis.
    Kelly C; Chalmers JD; Crossingham I; Relph N; Felix LM; Evans DJ; Milan SJ; Spencer S
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012406. PubMed ID: 29543980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis.
    Laska IF; Crichton ML; Shoemark A; Chalmers JD
    Lancet Respir Med; 2019 Oct; 7(10):855-869. PubMed ID: 31405826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.
    Zhuo GY; He Q; Xiang-Lian L; Ya-Nan Y; Si-Te F
    Pulm Pharmacol Ther; 2014 Oct; 29(1):80-8. PubMed ID: 24594263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial.
    Chang AB; Grimwood K; Wilson AC; van Asperen PP; Byrnes CA; O'Grady KA; Sloots TP; Robertson CF; Torzillo PJ; McCallum GB; Masters IB; Buntain HM; Mackay IM; Ungerer J; Tuppin J; Morris PS
    Trials; 2013 Feb; 14():53. PubMed ID: 23421781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of inhaled hypertonic saline for bronchiectasis: a meta-analysis of randomized controlled studies.
    Xie B; Liu P; Wu Q; Xiang W
    Am J Emerg Med; 2020 Dec; 38(12):2713-2717. PubMed ID: 33046287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.
    Altenburg J; de Graaff CS; Stienstra Y; Sloos JH; van Haren EH; Koppers RJ; van der Werf TS; Boersma WG
    JAMA; 2013 Mar; 309(12):1251-9. PubMed ID: 23532241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial.
    Goyal V; Grimwood K; Byrnes CA; Morris PS; Masters IB; Ware RS; McCallum GB; Binks MJ; Marchant JM; van Asperen P; O'Grady KF; Champion A; Buntain HM; Petsky H; Torzillo PJ; Chang AB
    Lancet; 2018 Oct; 392(10154):1197-1206. PubMed ID: 30241722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.
    Chalmers JD; Boersma W; Lonergan M; Jayaram L; Crichton ML; Karalus N; Taylor SL; Martin ML; Burr LD; Wong C; Altenburg J
    Lancet Respir Med; 2019 Oct; 7(10):845-854. PubMed ID: 31405828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
    Valery PC; Morris PS; Byrnes CA; Grimwood K; Torzillo PJ; Bauert PA; Masters IB; Diaz A; McCallum GB; Mobberley C; Tjhung I; Hare KM; Ware RS; Chang AB
    Lancet Respir Med; 2013 Oct; 1(8):610-620. PubMed ID: 24461664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term macrolide treatment for non-cystic fibrosis bronchiectasis in children: a meta-analysis.
    Lee E; Sol IS; Kim JD; Yang HJ; Min TK; Jang GC; Hwang YH; Cho HJ; Suh DI; Kim K; Kim HS; Kim YH; Woo SI; Lee YJ; Jung S; Jeon YH
    Sci Rep; 2021 Dec; 11(1):24287. PubMed ID: 34930997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial.
    Goyal V; Grimwood K; Ware RS; Byrnes CA; Morris PS; Masters IB; McCallum GB; Binks MJ; Smith-Vaughan H; O'Grady KF; Champion A; Buntain HM; Schultz A; Chatfield M; Torzillo PJ; Chang AB
    Lancet Respir Med; 2019 Sep; 7(9):791-801. PubMed ID: 31427252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison.
    Li W; Qin Z; Gao J; Jiang Z; Chai Y; Guan L; Chen Y
    Chron Respir Dis; 2019; 16():1479972318790269. PubMed ID: 30101613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial.
    Valery PC; Morris PS; Grimwood K; Torzillo PJ; Byrnes CA; Masters IB; Bauert PA; McCallum GB; Mobberly C; Chang AB
    BMC Pediatr; 2012 Aug; 12():122. PubMed ID: 22891748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial.
    Chang AB; Grimwood K; Robertson CF; Wilson AC; van Asperen PP; O'Grady KA; Sloots TP; Torzillo PJ; Bailey EJ; McCallum GB; Masters IB; Byrnes CA; Chatfield MD; Buntain HM; Mackay IM; Morris PS
    Trials; 2012 Aug; 13():156. PubMed ID: 22937736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled antibiotics therapy for stable non-cystic fibrosis bronchiectasis: a meta-analysis.
    Xu MJ; Dai B
    Ther Adv Respir Dis; 2020; 14():1753466620936866. PubMed ID: 32615859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled corticosteroids for bronchiectasis.
    Kapur N; Petsky HL; Bell S; Kolbe J; Chang AB
    Cochrane Database Syst Rev; 2018 May; 5(5):CD000996. PubMed ID: 29766487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchiectasis.
    Diego AD; Milara J; Martinez-Moragón E; Palop M; León M; Cortijo J
    Respirology; 2013 Oct; 18(7):1056-62. PubMed ID: 23714268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of macrolide maintenance therapy for prevention of disease exacerbations in patients with noncystic fibrosis bronchiectasis.
    Wang D; Fu W; Dai J
    Medicine (Baltimore); 2019 Apr; 98(17):e15285. PubMed ID: 31027086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.